Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-12-31

Clinical Trial Update: Efficacy and Safety of Palonosetron Hydrochloride in the Prevention of Nausea and Vomiting [Phase 4]

View source ↗

Summary

Phase 4 trial update reports on the efficacy and safety of palonosetron hydrochloride for preventing chemotherapy-induced nausea and vomiting; the study has com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Palonosetron hydrochloride (Palonosetron hydrochloride)

Snippet

Sponsor: Shanghai Changzheng Hospital | Conditions: Neoplasms, Chemotherapy-Induced Nausea and Vomiting | Phase 4 | Status: COMPLETED